Stirnemann J, Serratrice J, Mann T, Louge P, et al. Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study). BMJ Open 2024;14:e084825.
PMID: 39613437